Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
Kai Beckmann

Kai Beckmann

Chairman and Group CEO, Merck KGaA

Appears in 1 story

Notable Quotes

"This transaction is an important milestone towards delivering on our mid- to long-term strategic agenda." — Kai Beckmann

Stories

Merck KGaA buys Bio-Techne in its biggest deal since 2015

Money Moves

Leading his first major acquisition since taking the top job in September 2025

Merck KGaA of Darmstadt, Germany, agreed to buy Bio-Techne, a Minneapolis company that makes the reagents, proteins, and imaging tools researchers use at the lab bench. The price is $73 a share in cash, about $11.3 billion, a 36% premium over the recent trading average.

Updated 2 hours ago